TXG:NSD-10X Genomics Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 14.81

Change

0.00 (0.00)%

Market Cap

N/A

Volume

1.85M

Analyst Target

USD 120.25
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-25 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
GEHC GE HealthCare Technologies Inc..

N/A

USD 36.79B
HQY HealthEquity Inc

N/A

USD 8.45B
TEM Tempus AI, Inc. Class A Common..

N/A

USD 7.92B
WAY Waystar Holding Corp. Common S..

N/A

USD 4.47B
BTSG BrightSpring Health Services, ..

N/A

USD 3.07B
PRVA Privia Health Group Inc

N/A

USD 2.46B
WGS GeneDx Holdings Corp.

N/A

USD 2.17B
OMCL Omnicell Inc

N/A

USD 2.10B
PINC Premier Inc

N/A

USD 2.10B
GDRX Goodrx Holdings Inc

N/A

USD 1.72B

ETFs Containing TXG

GGMUSY:SW UBS (Irl) ETF plc - Solac.. 4.91 % 0.00 %

N/A

USD 0.17B
ZGD:CA BMO Equal Weight Global G.. 3.32 % 0.61 %

N/A

CAD 0.07B
ARKG ARK Genomic Revolution ET.. 0.00 % 0.75 %

N/A

USD 1.10B
PZC:CA 0.00 % 0.67 %

N/A

N/A
GOAU U.S. Global GO GOLD and P.. 0.00 % 0.60 %

N/A

USD 0.09B
UBUD:F UBS (Irl) ETF Public Limi.. 0.00 % 0.00 %

N/A

USD 0.17B
UBUD:XETRA UBS (Irl) ETF plc - Solac.. 0.00 % 0.00 %

N/A

USD 0.12B

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.13% 43% F 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.13% 43% F 59% D-
Trailing 12 Months  
Capital Gain -65.73% 13% F 10% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -65.73% 13% F 10% F
Trailing 5 Years  
Capital Gain -85.65% 30% F 12% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -85.65% 30% F 12% F
Average Annual (5 Year Horizon)  
Capital Gain -7.78% 48% F 23% F
Dividend Return -7.78% 46% F 22% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 69.51% 30% F 29% F
Risk Adjusted Return -11.19% 50% F 27% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.